Share this post on:

Product Name :
PD-116948

Search keywords :
DPCPX

drugId :
null

Target Vo:
Adenosine A1 receptor

Target Vo Short Name :
ADORA1

Moa_Name:
Adenosine A1 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sciclone Pharmaceuticals

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Cystic Fibrosis

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Faricimab medchemexpress
Itepekimab Autophagy
RNA Polymerase II Subunit B1 Antibody: RNA Polymerase II Subunit B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 217 kDa, targeting to RNA Polymerase II Subunit B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related